LogicBio Therapeutics (LOGC) Announces Proposed Common Offering

Go back to LogicBio Therapeutics (LOGC) Announces Proposed Common Offering

LogicBio Therapeutics Announces Proposed Public Offering of Common Stock

September 30, 2020 4:01 PM UTC

LEXINGTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq: LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of the offering, LogicBio intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering on the same terms and conditions. All shares being offered are to be sold by LogicBio.

... More